London’s Life Sciences resilience

Merck recently announced its withdrawal from a planned £1bn expansion in King’s Cross. Yet MedCity claims, “London’s life sciences ecosystem remains resilient and globally competitive with record VC investment, unparalleled access to health data and more than 6m sq ft of lab space in development”.

Leave a Comment

Your email address will not be published. Required fields are marked *

*
*

Latest articles

Geopolitics

Scénarios géostratégiques baltes : note de l’Institut Montaigne

Mentionnée notamment par le Monde Rappel de l’article 42 §7 du Traité More

Corporate Venture

Mantra’s Niche Private Equity Index Q4 2025

Published 4 November 2025. Mantra’s Index highlights the niche private equity strategies More

Artificial Intelligence

CB Insights’ State of AI Global Q3 2025

Growing market (#3 by recruitments): Defence & National security AI copilots